Wirkstoffe & Arzneimittelsicherheit

Nebenwirkungen · Roclanda

Roclanda 50 micrograms/ml + 200 micrograms/ml eye drops, solution · Abschnitt 4.8 · PDF-Seite 6–7

HOS-144344 · Präparat HOS-099162

6  System organ classification Frequency Adverse reactions Eczema eyelids3, Blepharal pigmentation, Eye disorder, Photophobia Rare Corneal oedema2, Corneal erosion2, Periorbital oedema2, Trichiasis2, Distichiasis2, Iris cyst2, Localised skin reaction on the eyelids2, Darkening of the palpebral skin of the eyelids2, Pseudopemphigoid of ocular conjunctiva2 Very rare Periorbital and lid changes resulting in deepening of the eyelid sulcus2 Not known Reticular epithelial corneal oedema3 Cardiac disorders Uncommon Angina2, Palpitations2 Very rare Angina unstable2 Respiratory, thoracic and mediastinal Uncommon Nasal discomfort3, disorders Asthma2, Dyspnoea2 Rare Asthma exacerbation2 Gastrointestinal disorders Uncommon Nausea, Vomiting Skin and subcutaneous tissue disorders Uncommon Dermatitis contact, Erythema, Skin disorder, Rare Pruritus2 Musculoskeletal and connective tissue Uncommon Myalgia2, disorders Arthralgia2, General disorders and administration site Uncommon Chest pain2 conditions 1 See Description of selected adverse reactions for further information 2 Additional adverse reaction observed with latanoprost monotherapy 3 Additional adverse reaction observed with netarsudil monotherapy

Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.